The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension (NCES) in Stable Resistant Vitiligo
Key facts
- Where
- Giza, EgyptSee the site
Where in Egypt
- Dermatology Department, Cairo University HospitalsGiza, EgyptContact: Rania MogawerNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Cairo University
- Trial code
- NCT06974669
- Record updated
- 16 May 2025
- Original description
Assessing the additive value of mini-oral pulse steroid therapy in surgical treatment of acral and difficult to treat sites of vitiligoRead full original descriptionShow less
The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension in Stable Resistant Vitiligo: An Interventional Prospective Controlled Trial.
Assessing the additive value of mini-oral pulse steroid therapy in surgical treatment of acral and difficult to treat sites of vitiligo
Inclusion: Patients with non-segmental vitiligo (NSV) with acral or resistant lesions over the elbows and knees, that has not responded to conventional treatment; Stability for ≥ 1 year; Age ≥18 years; Lack of topical treatment for at least 1 month prior to surgery and systemic treatment for at least 3 months prior to surgery.
Exclusion: Patients with hypertension, diabetes or tuberculosis; Age < 18 years; Non acral NSV responsive to conventional treatment modalities; Active vitiligo; new lesions, expansion of old lesions, confetti like lesions, ill-defined edges or koebnerization in < 1 year; Pregnant females; Topical treatment in the past month and systemic treatment in the past 3 months.